338 related articles for article (PubMed ID: 29444470)
1. Effect of sirolimus on liver cirrhosis and hepatic encephalopathy of common bile duct-ligated rats.
Wu KC; Huang HC; Chang T; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Lee FY; Chang CC; Lee SD
Eur J Pharmacol; 2018 Apr; 824():133-139. PubMed ID: 29444470
[TBL] [Abstract][Full Text] [Related]
2. Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats.
Chang CC; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Chang T; Huang HC; Lee FY; Lee SD
Eur J Pharmacol; 2017 May; 802():36-43. PubMed ID: 28238769
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats.
Hsu SJ; Wang SS; Huo TI; Lee FY; Huang HC; Chang CC; Hsin IF; Ho HL; Lin HC; Lee SD
J Pharmacol Exp Ther; 2015 Oct; 355(1):117-24. PubMed ID: 26260462
[TBL] [Abstract][Full Text] [Related]
4. The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis.
Tung HC; Lee FY; Wang SS; Tsai MH; Lee JY; Huo TI; Huang HC; Chuang CL; Lin HC; Lee SD
PLoS One; 2015; 10(5):e0124654. PubMed ID: 25933224
[TBL] [Abstract][Full Text] [Related]
5. Sodium-Glucose Cotransporter-2 Inhibition Exacerbates Hepatic Encephalopathy in Biliary Cirrhotic Rats.
Hsu SJ; Huang HC; Pun CK; Chang CC; Chuang CL; Huang YH; Hou MC; Lee FY
J Pharmacol Exp Ther; 2022 Oct; 383(1):25-31. PubMed ID: 35926870
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
Huang HC; Wang SS; Hsin IF; Chang CC; Lee FY; Lin HC; Chuang CL; Lee JY; Hsieh HG; Lee SD
Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2.
Wang W; Yan J; Wang H; Shi M; Zhang M; Yang W; Peng C; Li H
PLoS One; 2014; 9(1):e83908. PubMed ID: 24404143
[TBL] [Abstract][Full Text] [Related]
8. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
9. Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats.
Huang HC; Tsai MH; Chang CC; Pun CK; Huang YH; Hou MC; Lee FY; Hsu SJ
Clin Sci (Lond); 2021 Dec; 135(24):2709-2728. PubMed ID: 34870313
[TBL] [Abstract][Full Text] [Related]
10. Portosystemic collaterals are not prerequisites for the development of hepatic encephalopathy in cirrhotic rats.
Hsin IF; Wang SS; Huang HC; Lee FY; Chan CY; Chang CC; Hsu CY; Lin HC; Lee SD
J Chin Med Assoc; 2012 Jan; 75(1):3-9. PubMed ID: 22240529
[TBL] [Abstract][Full Text] [Related]
11. Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats.
Chang T; Ho HL; Hsu SJ; Chang CC; Tsai MH; Huo TI; Huang HC; Lee FY; Hou MC; Lee SD
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454890
[TBL] [Abstract][Full Text] [Related]
12. Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure.
Hsu CY; Lee FY; Huo TI; Chan CY; Huang HC; Lin HC; Chang CC; Teng TH; Wang SS; Lee SD
J Gastroenterol Hepatol; 2010 Jul; 25(7):1321-8. PubMed ID: 20594263
[TBL] [Abstract][Full Text] [Related]
13. Nucleos(t)ide Analogs Do Not Independently Influence Hepatic Fibrosis and Portal Hypertension beyond Viral Suppression in CBDL-Induced Cirrhotic Rat.
Hsieh YH; Huang HC; Chang CC; Chuang CL; Lee FY; Hsu SJ; Huang YH; Hou MC; Lee SD
J Pharmacol Exp Ther; 2018 Nov; 367(2):260-266. PubMed ID: 30194095
[TBL] [Abstract][Full Text] [Related]
14. Methimazole alleviates hepatic encephalopathy in bile-duct ligated cirrhotic rats.
Chang CC; Chen YC; Huang HC; Lee FY; Chang FY; Lin HC; Chan CY; Wang SS; Lee SD
J Chin Med Assoc; 2006 Dec; 69(12):563-8. PubMed ID: 17182349
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine deteriorates intrahepatic derangement and portal-systemic collaterals in cirrhotic rats.
Tung HC; Hsu SJ; Tsai MH; Lin TY; Hsin IF; Huo TI; Lee FY; Huang HC; Ho HL; Lin HC; Lee SD
Clin Sci (Lond); 2017 Jan; 131(1):69-86. PubMed ID: 27803296
[TBL] [Abstract][Full Text] [Related]
16. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.
Brusilovskaya K; Königshofer P; Lampach D; Szodl A; Supper P; Bauer D; Beer A; Stift J; Timelthaler G; Oberhuber G; Podesser BK; Seif M; Zinober K; Rohr-Udilova N; Trauner M; Reiberger T; Schwabl P
United European Gastroenterol J; 2020 Dec; 8(10):1174-1185. PubMed ID: 32878579
[TBL] [Abstract][Full Text] [Related]
17. Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats.
Hsu SJ; Lee FY; Wang SS; Hsin IF; Lin TY; Huang HC; Chang CC; Chuang CL; Ho HL; Lin HC; Lee SD
Hepatology; 2015 May; 61(5):1672-84. PubMed ID: 25557829
[TBL] [Abstract][Full Text] [Related]
18. The beneficial effects of curcumin in cirrhotic rats with portal hypertension.
Hsu SJ; Lee JY; Lin TY; Hsieh YH; Huang HC; Lee FY; Lin HC; Hou MC; Lee SD
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162665
[TBL] [Abstract][Full Text] [Related]
19. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes.
Hsin IF; Huang HC; Chang CC; Hsu SJ; Lee FY; Huo TI; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Nov; 132(22):2391-2405. PubMed ID: 30348829
[TBL] [Abstract][Full Text] [Related]
20. The influence of sorafenib on hepatic encephalopathy and the mechanistic survey in cirrhotic rats.
Hsu SJ; Hsin IF; Lin YL; Chen YC; Huang HC; Lee FY; Lin HC; Chang CC; Lee SD
Eur J Clin Invest; 2012 Dec; 42(12):1309-16. PubMed ID: 23078180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
